Mounjaro vs Ozempic in India (2026): Price, Side Effects & Which Is Better

Mounjaro Loses More Weight, but Ozempic Costs Far Less.

So Which One Is Actually Right for You in India? Here’s the Honest Answer.

A patient-friendly guide by RealMedVision
Medically Reviewed: June 2026 | Last Updated: June 2026 | 10-12 minutes read

Key Takeaways

The Mounjaro vs Ozempic choice mostly comes down to weight loss versus cost.

Mounjaro (tirzepatide) took off more weight in the head-to-head trial, around 20 percent against about 14 percent for Ozempic.

Ozempic (semaglutide) costs less, now has a low-cost generic in India, and has stronger proof that it guards the heart and kidneys.

Branded Ozempic costs about 5,660 to 9,100 rupees a month. Mounjaro costs about 13,000 to 27,500 rupees.

Mounjaro works on two gut hormones, GIP and GLP-1. Ozempic works on one, GLP-1. That is the main reason their results differ.

In India, Mounjaro is approved for both obesity and type 2 diabetes. Ozempic is approved for diabetes, and doctors use it off-label for weight.

Both are once-a-week injections with similar stomach side effects. Neither works alone, and both need a doctor’s guidance.

Introduction

Mounjaro vs Ozempic comes down to one simple trade-off in 2026. Mounjaro (tirzepatide) usually takes off more weight and lowers blood sugar a little more, but it costs more each month in India. Ozempic (semaglutide) costs less, is cheaper still as a generic, and has stronger proof that it protects the heart and kidneys. Both are once-a-week injections for type 2 diabetes, and both are widely used to help people lose weight.

If a doctor has suggested one of these, it’s normal to feel unsure. The names sound alike, the prices look high, and opinions online are loud. This guide lays out the real differences in plain words. The Mounjaro vs Ozempic choice is not about which drug is “best” in general. It is about which one fits your body, your budget, and your health goals.

Quick Answer

If your goal is the most weight loss, Mounjaro usually works better than Ozempic. If cost and long-term heart protection matter more, Ozempic is often the better choice. Both medicines lower blood sugar well, but the right option depends on your health, your budget, and your doctor’s advice.

What Mounjaro and Ozempic actually are

Both medicines belong to a group often called GLP-1 drugs. GLP-1 is a natural gut hormone. It tells your body to release insulin, slow down digestion, and feel full sooner.

Ozempic is the brand name for semaglutide. It copies that one hormone, GLP-1. Novo Nordisk makes it. India’s drug regulator, the CDSCO, approved it in 2025, and it reached Indian pharmacies in December 2025. In India it is approved to treat type 2 diabetes. Many people also use it off-label for weight, which means for a purpose outside the official label, always under a doctor’s care.

Mounjaro is the brand name for tirzepatide. It is newer, and it works on two hormones at once: GLP-1 and a second one called GIP, a partner gut hormone that helps control sugar and appetite. Eli Lilly makes it. Mounjaro launched in India in March 2025 and is approved for both type 2 diabetes and obesity.

That second hormone is the main reason the two drugs behave differently. Hitting two targets instead of one seems to give Mounjaro a bit more control over appetite and blood sugar. This sits at the centre of every Mounjaro vs Ozempic comparison that follows.

Mounjaro vs Ozempic: the quick comparison

The short version first.

Weight loss: what the studies show

On weight loss, the Mounjaro vs Ozempic gap is the clearest part of the whole picture. The best evidence comes from a 2025 trial called SURMOUNT-5, published in the New England Journal of Medicine. It was the first large study to put the two drugs head to head. Adults with obesity, but without diabetes, took either drug at its top dose for about 17 months.

The people on Mounjaro lost about 20 percent of their body weight. The people on Ozempic lost about 14 percent. In real numbers, that was around 22 kg on Mounjaro and about 15 kg on Ozempic. Dr Louis Aronne of Weill Cornell Medicine, who led the trial, said the results closely matched earlier separate studies.

One honest note: this study compared Mounjaro against the higher, weight-loss dose of semaglutide, the one sold as Wegovy. So for pure ozempic vs mounjaro for weight loss, Mounjaro comes out ahead, though the gap in daily practice depends on your dose and how your body responds.

A separate 2021 trial in people with type 2 diabetes, called SURPASS-2, found the same pattern. Mounjaro at its highest dose led to more weight loss than Ozempic at its standard diabetes dose.

These trials used different doses and groups, so the numbers are a guide, not a promise.

Blood sugar and HbA1c

If you live with diabetes, the number that matters most is your HbA1c. It is a blood test that shows your average sugar over about three months. Lower is usually better.

In the SURPASS-2 trial, Mounjaro lowered HbA1c a little more than Ozempic. The highest Mounjaro dose dropped it by about 2.4 percentage points against about 1.9 for Ozempic. Both are strong results. The difference is real but modest.

Here Ozempic has an edge the weight numbers miss. Semaglutide has years of large studies showing it lowers the risk of serious heart events and helps protect the kidneys in people with type 2 diabetes. Mounjaro is newer, and its long-term heart and kidney studies are still being reviewed. So for someone whose main worry is heart or kidney safety, that longer track record counts for a lot.

Mounjaro vs Ozempic price in India

This is where many people decide, and 2026 changed the picture. When you compare mounjaro vs ozempic price in India today, Ozempic is the cheaper branded option.

Branded Ozempic now costs roughly 5,660 to 9,100 rupees a month, depending on your dose, after Novo Nordisk cut its India prices in April 2026. Mounjaro runs from about 13,000 rupees for the starter dose to around 27,500 rupees a month at the top dose. So on monthly mounjaro vs ozempic cost, Mounjaro is often two to three times more expensive.

There is a bigger shift too. In March 2026, the patent on semaglutide expired in India, and local companies launched generic versions. Bloomberg reported starting prices as low as about 1,290 rupees a month, a drop of nearly 90 percent from the branded pen. There is no generic tirzepatide yet, and one is not expected for a few years, so Mounjaro has no cheaper copy right now.

Both drugs cost far more abroad. In the United States, each runs roughly 900 to 1,100 dollars a month before insurance, and UK private-clinic prices are well above India’s, too. One more thing to plan for: Indian health insurance usually does not cover these injections when used for weight loss, so most people pay out of pocket. You can check the current Mounjaro price and the current Ozempic price in more detail in our separate guides.

Ozempic vs Mounjaro side effects

On safety, the Mounjaro vs Ozempic picture is much closer. Because both drugs work in a similar way, they share most of the same side effects. The common ones hit the stomach, mostly in the first few weeks and when the dose goes up. They usually settle as your body adjusts.

When people compare ozempic vs mounjaro side effects, the pattern is close but not identical. In studies, nausea was reported a bit more often with Ozempic. Loose motions, or diarrhoea, showed up a bit more often with Mounjaro. Vomiting was similar for both, around 1 in 20 people. A slightly higher number of people stopped Mounjaro because of stomach trouble.

These figures come from separate trials, so they cannot be compared exactly. Your own experience depends on your dose and body.

Both drugs also carry rarer but serious risks. These include swelling of the pancreas, called pancreatitis, gallbladder problems, and low blood sugar if you also take insulin or certain diabetes tablets. Both carry a boxed warning, the strongest warning a medicine can have, about a rare thyroid tumor seen in animal studies. People with a personal or family history of medullary thyroid cancer, or a condition called MEN2, should not use either drug. Neither is safe in pregnancy. Tell your doctor your full history before you start.

Tirzepatide vs Semaglutide: What’s the Difference?

The brand names get the attention, but the active medicines are what your doctor and pharmacist actually prescribe. Ozempic is the brand. Semaglutide is the medicine inside it. Mounjaro is the brand. Tirzepatide is the medicine inside it.

The core tirzepatide vs semaglutide difference is how many targets each one hits. Semaglutide acts on a single hormone pathway. Tirzepatide acts on two. That extra target is why tirzepatide tends to edge ahead on weight loss and blood sugar in studies.

This matters in India for a practical reason. As generic versions arrive, they are sold under the molecule name, not the brand. A generic semaglutide pen may carry an Indian company’s name rather than Ozempic. Knowing the molecule helps you check that you are getting the right medicine at the right dose.

Where Wegovy fits in

You have probably seen the name Wegovy too. Here is the simple map of wegovy vs ozempic vs mounjaro. Wegovy and Ozempic are the same medicine, semaglutide. Ozempic is the diabetes version, and Wegovy is the higher-dose weight-loss version. Mounjaro is the separate dual-hormone drug. So the weight-loss race is really Wegovy against Mounjaro, with Ozempic used off-label by many.

Is Mounjaro really better than Ozempic?

Ask why Mounjaro is better than Ozempic, and online you will get a one-sided answer. The truth is more balanced. Mounjaro is better on paper for weight loss and blood sugar. But better on average does not mean better for everyone.

Ozempic wins on cost, generic availability, and proven heart and kidney protection. For someone with diabetes and heart disease on a tight budget, Ozempic or a generic semaglutide may be the safer choice. For someone whose main goal is major weight loss and who can afford it, Mounjaro may be worth the higher price. Decide this with your doctor, not from a headline.

Which one might suit you?

There is no single winner in the Mounjaro vs Ozempic question. The right pick depends on your goals, budget, and other conditions.

Clinical note: No medicine works the same for everyone. Age, weight, HbA1c level, kidney function, and other health conditions all affect treatment decisions.

This table is a starting point for a conversation, not medical advice for your case.

The bigger picture

Whichever way the Mounjaro vs Ozempic decision goes, the injection is only part of the plan. Both drugs work best alongside steady changes to food and daily movement, and both are for long-term use.

If your blood sugar is only slightly high, you may not need either drug yet. Learning the early signs of diabetes, understanding prediabetes, and how to reverse prediabetes with diet and activity can protect you before medicine is needed. Ask your doctor where you stand first.

When to see a doctor

These are prescription medicines, so a doctor should guide you from day one. Some signs need faster attention.

Get medical help the same day or go to the nearest emergency room if you have severe stomach pain that will not ease, especially pain that spreads to your back, along with vomiting. This can be a sign of pancreatitis.

Book an appointment soon if you have signs of very low blood sugar, such as shaking, sweating, and confusion, or if you cannot keep fluids down for more than a day. See your doctor before you start if thyroid cancer runs in your family, if you have had gallbladder disease or serious stomach problems, or if you are pregnant, breastfeeding, or planning a baby.

Frequently asked questions

Is tirzepatide the same as semaglutide?

No. Tirzepatide (Mounjaro) and semaglutide (Ozempic) are different medicines. Semaglutide works on one gut hormone. Tirzepatide works on two. In the tirzepatide vs semaglutide studies, tirzepatide gave slightly more weight loss and blood sugar control, though both work well.

Can I use Mounjaro or Ozempic for weight loss if I don’t have diabetes?

A doctor can prescribe them for weight when it fits your health needs. In India, Mounjaro is approved for obesity, while Ozempic is approved for diabetes and used off-label for weight. Wegovy is the semaglutide version made for weight loss.

Is the generic version as good as branded Ozempic?

A generic approved by India’s regulator contains the same semaglutide molecule and works the same way. The main differences are the maker, the pen or vial format, and the price. Ask your doctor which brand is reliable.

Which is cheaper in India, Mounjaro or Ozempic?

Ozempic is cheaper. After the 2026 price cut, branded Ozempic costs about 5,660 to 9,100 rupees a month, while Mounjaro costs about 13,000 to 27,500 rupees. Generic semaglutide is cheaper still.

Can I switch from Ozempic to Mounjaro?

Some people do, usually for more weight loss or better sugar control. It should always be done with a doctor, who will restart you at a low Mounjaro dose to limit stomach side effects.

How fast will I see results?

Most people notice changes over the first two to three months, not in days. The dose is raised slowly on purpose, and results are best when the injection is paired with better food habits and more activity.

Will I regain weight if I stop taking Mounjaro or Ozempic?

Often, yes. In follow-up studies, most people regained a large part of the weight within a year of stopping either drug. Doctors now treat obesity as a long-term condition, so these medicines are usually meant for ongoing use, not a short course. Any plan to stop should be made with your doctor.

Can I take Mounjaro or Ozempic with metformin?

Yes, this is common. Many people take one of these injections alongside metformin, and the main head-to-head trials were done in people already using metformin. Your doctor will set the right combination and adjust other diabetes medicines if needed.

Do I need a prescription to buy Mounjaro or Ozempic in India?

Yes. Both are prescription-only medicines. They are not meant to be bought over the counter or online without a doctor, because the dose is raised in steps and you need checks for side effects along the way.

Are Mounjaro and Ozempic safe for long-term use?

Current evidence supports long-term use under medical care, and guidelines no longer cap these drugs at a fixed short period. Long-term safety is still being studied, especially for the newer medicine, tirzepatide. Regular follow-up with your doctor is the safe way to stay on either one.

References

1. New England Journal of Medicine. Tirzepatide as compared with semaglutide for the treatment of obesity: the SURMOUNT-5 head-to-head trial. 2025.
2. New England Journal of Medicine. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes: the SURPASS-2 trial. 2021.
3. Weill Cornell Medicine. A head-to-head trial compares two weight-loss drugs. 2025.
4. American College of Cardiology. SURMOUNT-5: greater loss of weight and waist circumference with tirzepatide than semaglutide. 2025.
5. American Diabetes Association. Pharmacologic approaches to glycemic treatment, Standards of Care in Diabetes. 2026.
6. NICE. Tirzepatide for managing overweight and obesity: technology appraisal guidance. 2025.
7. NICE. Semaglutide for managing overweight and obesity: technology appraisal guidance. 2023.
8. Drugs.com. Mounjaro and Ozempic, how do they compare? 2026.
9. SingleCare. Ozempic versus Mounjaro side effects. 2025.
10. Diabetes Obesity and Metabolism. Weight regain and cardiometabolic effects after withdrawal of semaglutide, the STEP 1 trial extension. 2022.
11. American College of Cardiology. Weight regain after tirzepatide withdrawal, a SURMOUNT-4 analysis. 2025.
12. Reuters. Novo Nordisk launches Ozempic in India. December 2025.
13. Business Standard. Novo Nordisk cuts Ozempic and Wegovy prices by 48 percent in India. April 2026.
14. Bloomberg. Generic Ozempic to launch in India at 14 dollars as the GLP-1 patent era starts. March 2026.
15. Bloomberg. Novo Nordisk’s Ozempic India price cut boosts obesity drug sales. May 2026.
16. CNBC. India is launching cheap weight-loss drugs, but Novo Nordisk is betting its brands stay on top. March 2026.

Medical Disclaimer

This article is for general education only. It is not medical advice and does not replace care from your own doctor. Mounjaro and Ozempic are prescription medicines. Do not start, stop, or change any treatment without talking to a qualified healthcare professional who knows your full history.

Medically Reviewed by

Dr. Praveen Verma, MBBS, MD (Pathology), Pathologist and Clinical Laboratory Specialist

Dr. Himanshu Morya, MBBS, Medical Educator and College Faculty

About the Author

Iraphan Khan, BSN, D.Pharm, CMLT, Founder of RealMedVision | Public Health Researcher

Iraphan Khan is the founder of RealMedVision, where he creates clear, evidence-based health content for patients and families using trusted medical sources like the WHO, ADA, and NHS.